SUMMARY Pseudouridylation (J) is the most abundant and widespread type of RNA epigenetic modification in living organisms; however, the biological role of J remains poorly understood. Here, we show that a J-driven posttranscriptional program steers translation control to impact stem cell commitment during early embryogenesis. Mechanistically, the J ''writer'' PUS7 modifies and activates a novel network of tRNA-derived small fragments (tRFs) targeting the translation initiation complex. PUS7 inactivation in embryonic stem cells impairs tRF-mediated translation regulation, leading to increased protein biosynthesis and defective germ layer specification. Remarkably, dysregulation of this posttranscriptional regulatory circuitry impairs hematopoietic stem cell commitment and is common to aggressive subtypes of human myelodysplastic syndromes. Our findings unveil a critical function of J in directing translation control in stem cells with important implications for development and disease.
INTRODUCTION
There is a growing realization that RNA modifications, evolutionarily conserved hallmarks of RNA, directly impact genetic information in development and disease (Blanco and Frye, 2014; Karijolich et al., 2015; Yue et al., 2015; Zipeto et al., 2015) . New research has uncovered complex networks of RNA modifiers that directly steer the cellular epigenetic RNA landscape to control central RNA-based processes such as transcription, splicing, and translation (Roundtree et al., 2017) . One of the most abundant and widespread nucleoside modifications in living organisms is the isomerization of uridine (U)-to-pseudouridine (J) , RNA pseudouridylation (Charette and Gray, 2000) . J is catalyzed by a family of evolutionarily conserved pseudouridine synthases (PUSs), which modify their RNA substrates as ''standalone'' enzymes or through an RNA-dependent mechanism that involves a multitude of antisense box H/ACA small nucleolar RNAs (snoRNAs) (Hamma and Ferré -D'Amaré , 2006) . Decades of research using different model organisms demonstrate that J possesses biochemical properties that directly impinge on RNA biogenesis, structure, function, and coding potential with important implications for cellular homeostasis through modification of regulatory RNAs such as spliceosomal RNAs (snRNAs), rRNAs, and tRNAs (Ge and Yu, 2013) . Building upon these studies, the discovery of mutations in genes encoding PUSs provided important evidence linking J impairments to the pathogenesis of severe human syndromes and cancer (Angrisani et al., 2014; Rintala-Dempsey and Kothe, 2017) . Together, this evidence sparked new interest in the biological functions of J and its contribution toward fundamental cellular processes involved in development and disease.
Recent advances in high-throughput J-sequencing approaches have shifted the paradigm for the role of RNA pseudouridylation in cells, illustrating that J is a dynamic and widespread component of cellular transcriptomes (Karijolich et al., 2015) . This led to the discovery of novel J sites within various types of RNA species not previously known to be modified, including a multitude of mRNAs from yeast to mammalian cells (Carlile et al., 2014; Li et al., 2015; Schwartz et al., 2014) . Remarkably, the majority of newly identified J sites are highly inducible within cells and are catalyzed predominantly by stand-alone PUSs, including the multi-substrate synthase PUS7 involved in stress-induced RNA J (Behm-Ansmant et al., 2003; Schwartz et al., 2014) . Despite these findings suggesting that J may provide a rapid means to rewire the genetic information within cells and tissues, there is still a major gap in our understanding of the posttranscriptional mechanisms by which PUS-mediated J impacts gene expression dynamics and cell function.
In this work, we uncovered that PUS7-mediated J ''activates'' a new class of tRNA-derived small RNAs to control protein synthesis and stem cell fate determination. Disruption of this J-driven regulatory circuitry critically impacts hematopoiesis and may contribute to human myeloid malignancies. These studies provide an unanticipated new layer of posttranscriptional gene regulation orchestrated by J that directly impacts central developmental and oncogenic programs.
RESULTS

PUS7 J Synthase Activity Impacts Stem Cell Size and Protein Biosynthesis
The contribution of J toward stem cell function through modification of the epigenetic RNA landscape has not been investigated. Hence, we sought to delineate the role of PUS-mediated J during embryogenesis. We first measured the levels of three evolutionarily conserved multisubstrate PUS enzymes, namely PUS1, PUS4, and PUS7 (Karijolich et al., 2015) , in an H9 human embryonic stem cell line (hESC) and IMR90 primary human fibroblasts (HF). Strikingly, PUS7 was selectively enriched in hESCs compared to PUS1 and PUS4, whose expression patterns did not change significantly (Figures 1A and S1A) . As expected, the snoRNA-guided J synthase Dyskerin was upregulated in line with previous findings illustrating its effects on transcription and telomere maintenance in pluripotent cells (Agarwal et al., 2010; Fong et al., 2014) . Based on these observations, we hypothesized that PUS7 functions to modify the J epitranscriptome of undifferentiated cells. Thus, we employed CRISPR/Cas9 to generate the first PUS7-knockout hESCs, denoted PUS7- KO (Sanjana et al., 2014) and study the role of PUS7-driven J in stem cells ( Figure 1B) . Surprisingly, there were no differences in cell proliferation, viability and expression of multiple pluripotency, and germ layer specific markers between wild-type (WT) and PUS7-KO cells maintained in culture over long periods of time without loss of self-renewal (A) PUS7 is a stem cell-enriched J synthase. Expression of PUS enzymes in human embryonic stem cells (hESCs) and fibroblasts (HFs). Right: Immunofluorescence shows nuclear localization of PUS7 in hESCs. (B) Schematic of CRISPR/Cas9-based mutagenesis of PUS7. Characterization of one PUS7-KO hESC clone is shown. (C) PUS7 loss does not affect pluripotency. Representative images of WT and PUS7-KO hESC colonies stained for alkaline phosphatase (AP), OCT4, and TRA-1-60. Heatmap shows expression levels of multiple pluripotency and lineage-specific markers in WT and PUS7-KO hESCs in four independent experiments. Color bar indicates normalized gene expression from +4 to À4 in log 2 space. No statistical significant differences were measured (t test). (D) Transmission electron micrographs of single cells reveal increased size of PUS7-KO hESCs. Scale bars, 5 mm. Close-up highlights nucleus (n) and cytoplasm (c) in WT and PUS7-KO cells. Graphs show mean cell surface and cytoplasm to nuclear area ratios ± SEM. **p < 0.01, *p < 0.05 (t test). (E) Translation is increased in PUS7-KO hESC. De novo protein synthesis measured by 35 S radioactive methionine/cysteine incorporation in WT and PUS7-KO cells ± wild-type (PUS7-WT) or J catalytically inactive PUS7 allele (PUS7-D294A). Graph shows relative rate of protein synthesis ± SD in at least three independent experiments. *p < 0.05; NS, no statistical significance (t test). See also Figures S1 and S2.
( Figures 1C, S1B , and S1C). However, we observed a significant increase in PUS7-KO cell size compared to controls (Figure 1D) . This suggested that PUS7 depletion might promote metabolic alterations impacting cell growth, for instance changes in mRNA translation. Indeed, de novo protein synthesis rates were remarkably elevated in PUS7-KO hESCs (Figure 1E) , which was consistent with a specific increase of cap-mediated translation in these cells ( Figure S1D ). Similar defects were observed in another PUS7-KO hESC independent clone (PUS7-KO2), ruling out possible clonal artifacts secondary to the CRISPR/Cas9-editing methodology . The increases in translation occurred without changes in rRNA abundance and were not associated with aberrant mTOR pathway activation or proteotoxic stressinduced eIF2a phosphorylation (Figures S1E-S1G, S2F, and S2G). Furthermore, increased protein synthesis in PUS7-KO cells was completely rescued to control levels by stable expression of a wild-type PUS7 allele (PUS7-WT) ( Figure 1E ). Critically, a PUS7 catalytic inactive mutant, designated PUS7-D294A, failed to rescue increased protein synthesis in PUS7-KO hESCs, suggesting that loss of PUS7-mediated J modifications was required for the translational alterations in these cells (Behm-Ansmant et al., 2003) ( Figure 1E ). These findings establish a selective role for PUS7-mediated J in governing the translational capacity of hESCs.
PUS7 Binds Specific tRNA Isoacceptors in hESCs
Previous studies in yeast have been instrumental in delineating the contribution of PUS7 to tRNA and snRNA pseudouridylation and in defining its J-consensus sequence ''UGUAR'' (R = G/A) containing the target uridine (U) (Behm-Ansmant et al., 2003 ). Yet, transcriptome-wide J profiling suggests that the repertoire of RNAs modified downstream of PUS7 is widespread and (C) Pie chart shows distinct categories of RNA species bound to PUS7 in hESCs identified by iCLIP-seq. (D) Sequence analysis of PUS7-specific iCLIP products identifies a new putative PUS7-RNAbinding motif.
(E) Pie chart shows enrichment of individual PUS7-bound tRNAs identified by iCLIP-seq normalized to their abundance in hESCs determined by smRNA-seq. See also Figure S3 and Table S1 .
dynamically regulated upon stress (Karijolich et al., 2015; Schwartz et al., 2014) . Nonetheless, a comprehensive analysis of the specific PUS7 RNA regulon in stem cells has not been performed. To chart genome-wide PUS7-RNA interactions at a single-nucleotide resolution in hESCs, we performed individual-nucleotide resolution UV cross-linking and immunoprecipitation followed by highthroughput sequencing (iCLIP-seq) (Huppertz et al., 2014) (Figure 2A) . Specifically, we isolated RNA from PUS7-KO cells reconstituted with an N-terminal FLAG tagged PUS7-WT ( FLAG-PUS7-WT) allele, which rescued the translational defect in these cells. Mock-infected PUS7-KO cells were used as a control to exclude non-specific RNA binding ( Figure 2B ). Strikingly, iCLIP-seq revealed several previously unknown PUS7-RNA interactions, including RNA polymerase III (Pol III) transcripts such as tRNAs, Y RNAs, vault (VT) RNAs, and U6 ( Figure 2C ; Table S1 ). Furthermore, PUS7 was bound to mRNAs and noncoding (nc) RNAs, mostly snoRNAs, consistent with previous data in yeast and mammalian cells (Behm-Ansmant et al., 2003; Carlile et al., 2014; Li et al., 2015; Schwartz et al., 2014) . Importantly, iCLIP-seq peak analysis identified a new putative binding motif ''GTT [CTA] [GA]A'' highly represented on tRNAs and other RNA species (52% of non-tRNAs) including VT RNAs, Y RNAs, snoRNAs, mRNAs, and ncRNAs extensively bound by PUS7 in hESCs ( Figures 2D and S3G ). Our computational analysis indicated that PUS7 might also bind other less enriched sequence motifs (data not shown). This suggests that PUS7 is likely to have a complex RNA-binding capacity, which may involve target recognition through secondary structures as recently proposed for the multi-substrate J synthase PUS4 (Safra et al., 2017) . We validated these results by knocking out PUS7 in human embryonic kidney 293 cells (HEK293T) that expressed PUS7 and observed a comparable high degree of PUS7-tRNA interactions and similar translational defects ( Figures S3A-S3E) .
tRNAs are central components of the translation machinery, and posttranscriptional modifications have been shown to affect their function in translation regulation (Chou et al., 2017; Kirchner and Ignatova, 2015) . Having identified the PUS7 tRNAome, we hypothesize that PUS7-mediated J might regulate translation by modulating tRNA levels. We first determined whether specific tRNA isoacceptors were bound by PUS7 in hESCs. Although tRNA sequencing is challenging due to their heavily modified status (Liu et al., 2016) , replicate iCLIP experiments were consistently enriched for specific PUS7-cognate tRNA interactions ( Figure 2E ; Table S1 ). Thus, we reasoned that PUS7 loss might perturb the levels of individual tRNA identified by iCLIPseq and performed next generation small RNA sequencing (smRNA-seq) on total RNA isolated from WT and PUS7-KO hESCs. Importantly, we did not observe significant differences in the frequency of individual mature tRNA isoacceptors including tRNA-Tyr (GUA), a primary PUS7 target in eukaryotic cells (Figures S3F and S4A-S4D) (Urban et al., 2009 ).
PUS7-Mediated J Directs tRNA-Derived Small RNAs to Inhibit Translation
Compelling evidence has revealed that in different organisms and cell types and upon various stress conditions, a small fraction of mature tRNAs is cleaved to produce a multitude of tRNA-derived fragments (tRFs) (Kumar et al., 2016) . Intriguingly, specific categories of tRFs processed from 5 0 ends of tRNAs function as potent inhibitors of protein synthesis (Kumar et al., 2016) . Building upon these studies and our findings that tRNA abundance is unperturbed by PUS7 loss, we investigated whether underlying tRF dysfunctions contributed to the translational alterations in PUS7-depleted cells. We interrogated smRNA-seq libraries generated using RNA from WT and PUS7-KO hESCs for differences in the major categories of tRFs including 5 0 /3 0 -derived tRFs (5 0 tRF and 3 0 tRF) and internalderived tRFs (int-tRF) (Loher et al., 2017) . Strikingly, we identified specific tRF subsets significantly altered in PUS7-KO cells, which were primarily processed from the 5 0 end of specific cognate tRNAs ( Figure 3A ; Table S2 ). Furthermore, we uncovered that 5 0 tRFs derived from tRNA containing a 5 0 terminal oligoguanine (TOG), such as tRNA-Ala, tRNA-Cys, and tRNA-Val, were significantly depleted in PUS7-KO cells ( Figures 3B, S4E , and S4F). Since TOG-containing fragments were previously shown to potently repress translation (Ivanov et al., 2011) , we further examined how PUS7 regulated this specific 5 0 tRF subgroup. Interestingly, the largest fraction of hESCs-enriched TOG-containing tRFs peaked at 18-mer; we denoted these small endogenous 5 0 tRFs as mini TOGs (mTOGs) given their short length ( Figures 3C and 3D) . The smRNA-seq data was verified using sequence-specific qRT-PCR, illustrating a drastic reduction ($50%) of mTOGs in PUS7-KO cells ( Figures 3E, S4F -S4H, and S5F) (Persson et al., 2009 ). This effect was specific as add-back of PUS7 completely rescued mTOGs levels, indicating that PUS7 may contribute to their biogenesis ( Figure 3E ). Furthermore, sequence analysis revealed that mTOGs share the specific PUS7 J-consensus motif containing the uridine residue at position 8 (U8) as a new predicted target residue for modification ( Figure 3D ). To reveal that the predicted U8 position was highly J in hESCs, we employed a modified version of a highly sensitive enzymatic-based method, denoted as SCARLET (site-specific cleavage and radioactive-labeling followed by ligation-assisted extraction and thin-layer chromatography) (Liu et al., 2013) (Figure 3F ). This was validated using a CMCT-based protocol optimized to accurately detect endogenous mTOG J8 levels (Persson et al., 2009; Schwartz et al., 2014) and demonstrate that this modification was PUS7 dependent .
Although predicted to harbor various types of RNA modifications, it is unknown how specific RNA epigenetic ''marks'' affect tRFs function. Having established that PUS7 modifies mTOGs, we next examined whether J was required for translational regulation. Thus, we measured protein synthesis in PUS7-KO hESCs transduced with differentially J synthetic mTOG oligos. Strikingly, we uncovered that only mTOG-J8 restored protein synthesis to control levels in these cells (Figures 3G and S5G) . This effect was not due to differences in mTOG levels, stability, or aspecific response induced by transduction of J-modified oligonucleotides ( Figures S5D and S5E ). Together, these results suggest that J is critically required for 5 0 tRF-dependent translational repression in vivo.
Pseudouridylated mTOG Inhibits Translation Initiation
Previous evidence suggests that stress-induced TOG-containing 5 0 tRFs impaired translation initiation by displacing eIF4A and eIF4G from the mRNA 7-methyl-guanylate cap (m 7 G), one of the earliest rate-limiting steps of translation initiation (Ivanov et al., 2011) . Hence, we performed cap-binding assays based on the rationale that translation initiation may be favored by loss of PUS7. Indeed, we found that eIF4A/G binding to eI-F4E:m 7 G was significantly increased in PUS7-KO cells (Figures 4A, S5H, and S5I) . Remarkably, we found that the presence of J8 was required for efficient mTOG-dependent displacement of eIF4A/G from m 7 G-coated Sepharose beads, confirming our data that mTOG-J8 selectively rescued increased protein synthesis in PUS7-KO cells (Figures 4B and S5J) . Similarly, genetic inhibition of the cap complex using a dominant negative version of 4EBP1 (4EBP1 M ) (Hsieh et al., 2010), a major negative regulator of cap-dependent translation, completely rescued de novo protein synthesis rates in PUS7-depleted cells (D) Schematic depicts the structure of tRNA Ala/Cys/Val with the mTOG sequence (blue). The PUS7 J-consensus motif (yellow), target J (red), and RNA-binding motif (green) are highlighted. (E) PUS7 regulates mTOG levels in hESCs. Graph shows mean mTOG expression levels in WT and PUS7-KO hESCs ± SD in three independent experiments measured by stem-loop specific qPCR. **p < 0.01; NS, no statistical significance (t test). (F) mTOGs are extensively pseudouridylated in hESCs. Synthetic oligos with or without J are employed as standards (Std) to determine the position of U and J nucleotides on the TLC plate during SCARLET. Endogenous levels of mTOG J modification at position 8 (J8) in hESCs are shown (bottom right). (G) Global protein synthesis measured by puromycin incorporation in WT and PUS7-KO hESCs transduced with 50 nM scramble control and mTOG-J8 or mTOG-U8 oligos. Graph shows relative rate of protein synthesis ± SD in three independent experiments. **p < 0.01 (t test). See also Figures S4 and S5 and Table S2 .
( Figure 4C ). Together, these results strongly suggest that eIF4E-mediated translation initiation is impaired in PUS7-KO cells.
Next, we sought to delineate the molecular basis for mTOGdriven translational repression in vivo. Recent studies using unmodified TOG-containing 5 0 tRFs indicated that eIF4G/A displacement from eIF4E might involve recruitment of trans-factors in a sequence-or structure-dependent manner (Ivanov et al., 2011; Lyons et al., 2017) . Thus, we optimized a pulldown strategy using PUS7-KO cells transduced with biotinylated scramble control or mTOG-J8 oligos and applied quantitative mass spectrometry (MS)-based proteomics to delineate the mTOG interactome in vivo (Boersema et al., 2009; Goodarzi et al., 2015) . This approach unraveled several new interactions between mTOGs and proteins involved in central RNA-based (A and B) eIF4F assembly is enhanced in PUS7-KO hESCs and selectively regulated by mTOG-J8 expression. 7-methyl-guanosine (m 7 GTP) pull-down assays illustrate eIF4G/A recruitment to eIF4E:m 7 GTP Sepharose beads in lysates from WT and PUS7-KO hESCs ± mTOG-J8 or mTOG-U8. Graphs show mean log 2 fold change (FC) ± SD of cap-bound eIF4E/G/A in at least three independent experiments. *p < 0.05, **p < 0.01; NS, no statistical significance (t test Figure S5 and Table S3. processes such as translation and splicing ( Figure 4D ; Table S3 ). These results were consistent in replicate experiments using both hESCs and HEK293T PUS7-KO cells. Since J is required for mTOG function, we performed independent pull-downs in hESCs to study whether J affected binding of candidate factors important for translation regulation. We discovered that J strongly and selectively increased the association between mTOGs and polyadenylate-binding protein 1 (PABPC1), a central initiation factor highly enriched in mTOG-J8 precipitates ( Figures 4E) . Unexpectedly, prominent tRF-binding proteins such as Y-box binding protein 1 (YBX1) and DEAH-box helicase 36 (DHX36) were instead mostly bound by unmodified mTOGs, whereas no significant differences were observed for RPL10A and RPL30 ( Figure 4E ). These results suggest that J may govern mTOG function by regulating the binding to specific proteins. PABPC1 is integral to the formation of the initiation complex, and its interaction with eIF4G is required to stimulate protein synthesis (Kahvejian et al., 2005) . Therefore, we investigated how the mTOG/PABPC1 association impacts translation regulation in hESCs. We found that the amount of cap-bound PABPC1 was significantly increased in PUS7-KO cells and was readily restored back to control levels by using mTOG-J8 ( Figure 4F ). Importantly, PABPC1 downregulation phenocopied mTOG-J8 expression completely rescuing translation levels in PUS7-KO hESCs ( Figure 4G ). Moreover, no additional reduction in protein synthesis was observed upon mTOGs transduction in these cells, strongly implicating PABPC1 in mTOG-dependent eIF4F repression. Taken together, these results provide key insights into the molecular basis underlying PUS7-mediated translational control in vivo.
PUS7 Loss Impacts Early Embryogenesis and Mesoderm Specification
Given that translation control is essential for accurate stem cell fate determination (Buszczak et al., 2014) , we explored the consequences of PUS7 loss on development by recapitulating early embryogenesis in vitro. To this end, we generated embryonic bodies (EB) and assessed differentiation toward the three primary germ layers: ectoderm, mesoderm, and endoderm (Keller, 2005) ( Figure 5A ). As expected, we observed a reduction in PUS7 (mRNA and protein) and mTOGs levels accompanied by increased protein synthesis during hESC differentiation ( Figures  5B, 5C , and S6A). Accordingly, PUS7-KO EBs showed abnormal levels of multiple lineage-specific markers ( Figure 5D ). Specifically, PUS7 depletion greatly impaired mesodermal production as shown by dramatic reductions of terminally differentiated cells positive for the mesoderm marker a-SMA/ACTA2 (Figure 5E ). These developmental defects indicated that aberrant gene expression programs might be readily established in hESCs as a consequence of impaired PUS7-mediated J. To test this possibility, we performed polysome profiling and qualitatively assessed the translatome of PUS7-KO hESCs through sucrose gradient purification of mRNAs associated with translationally active ribosomes (polysomes) (Sagliocco et al., 1996) . This unbiased approach enabled us to identify specific defects in translation affecting multiple transcripts in PUS7-KO hESCs linked to developmental processes associated with embryogenesis, mesoderm differentiation such as somitogenesis, bone formation, and angiogenesis (Figures S6B-S6D ; Table S4 ). These findings support the idea that PUS7-mediated J may direct gene expression posttranscriptionally during early embryogenesis.
Next, we reasoned that aberrant protein synthesis downstream of PUS7 loss might impact production of hematopoietic cells that develop from the mesoderm germ layer (Keller, 2005) . To this end, we transduced PUS7-KO hESCs with control and mTOG-J8 or mTOG-U8 oligos and assessed hematopoietic commitment ( Figures 5F and S6E) . Significantly, we found that mTOG-J8 expression specifically restored protein synthesis and hematopoietic differentiation defects in PUS7-KO cells (Figures 5F , 5G, and S6H). This occurred without reductions in number, viability, and proliferation of hESC-derived hematopoietic stem and progenitor cells (HSPC) (Figures S6I-S6K Figures S7G and S7H ). The differentiation blockage was confirmed by flow cytometry analysis of colonies grown in methylcellulose illustrating drastic loss of cells harboring the PUS7 shRNA, which remained mostly undifferentiated (CD34+) ( Figures S7I and S7J ). As expected, we found that PUS7-mediated J governed hematopoietic commitment as differentiation of PUS7-depleted HSPCs was restored only upon transduction of mTOG-J8 ( Figures 6C and S7C ). To investigate the in vivo effects of PUS7 loss, we performed xenotransplantation of primary human HSPCs infected with control or two distinct PUS7 shRNA-expressing lentiviruses into immunocompromised NOD/SCID/g (NSG) mice ( Figure 6D ). Transduction efficiencies were comparable between control and PUS7 knockdown groups at time of transplantation with $80% of transduced GFP+/CD34+ HSPCs ( Figure 6E ). However, human multilineage engraftment within the peripheral blood (PB) of mice reconstituted with PUS7-depleted HSPCs was dramatically impaired (Figures 6F, 6G, and S7K) . This defect was associated with a significant loss of PUS7-depleted hematopoietic cells (hCD45+/ GFP+) evident already 4 weeks post-transplantation. Similarly, we found a profound reduction of human hematopoietic chimerism in the bone marrow (BM) of PUS7 knockdown xenografts ( Figure 6G ). These results highlight the importance of the PUS7-mTOG axis for HSPCs function in vivo.
PUS7 Dysregulation in Human Myelodysplastic Syndromes
Since increased protein synthesis has been shown to perturb HSC function contributing to leukemogenesis (Signer et al., 2014) , we examined whether PUS7 dysfunction contributed to hematological malignancies. Our survey in human cancers revealed that loss of PUS7 occurred in conjunction with chromosome 7 abnormalities frequent in myelodysplastic syndromes (MDS), hematological clonal disorders characterized by HSPC dysfunction and high risk for transformation to acute myeloid leukemia (AML) ( Figure 7A ) (Bagger et al., 2016; Sperling et al., 2017). Although evidence suggest that monosomy 7 (À7) or deletions del(7q) may underlie MDS pathogenesis (Jerez et al., 2012) , the genetic bases remain unclear. To study the clinical implications of PUS7 somatic loss, we isolated HSPCs from the BM of newly diagnosed À7 MDS patients and found PUS7 and mTOG levels to be remarkably reduced ( Figure 7B ; Table S5 ). Strikingly, these defects were linked to significantly higher protein synthesis rates in BM mononuclear cells (MNCs) derived from the same À7 MDS patients compared to healthy controls ( Figure 7C Graph shows percentage of a-SMA+ cells derived from WT or PUS7-KO hESCs ± SD in three independent experiments. **p < 0.01 (t test). (F) Schematic showing hESC-derived hematopoietic differentiation. Representative images of methylcellulose plates illustrate rescue of hematopoietic differentiation only by mTOG-J8 expression in PUS7-KO cells. Graph shows colony number ± SD in three independent experiments. **p < 0.01; NS, no statistical significance (t test). (G) Protein synthesis analysis in WT, PUS7-KO, and PUS7-KO ± mTOG-J8 or mTOG-U8 hESC-derived HSPCs. Graph shows relative rates of protein synthesis ± SD in three independent experiments. *p < 0.05; NS, no statistical significance (t test). See also Figure S6 and Table S4 .
DISCUSSION
This study unveils a new critical role for RNA pseudouridylation in governing global protein synthesis and cell fate determination. Remarkably, we identify the stem cell-enriched J ''writer'' PUS7 as a critical regulator of a novel endogenous subset of tRFs, which modulate translation rates to impact stem cell growth and differentiation ( Figure 7D ). Previous studies illustrated a role for tRFs in translation control (Kumar et al., 2016) ; however, the regulatory mechanisms and implications for fundamental cellular processes such as development and tumorigenesis remain poorly understood. Here, we identify a novel J epigenetic program governing stem cell-enriched small 5 0 tRFs sharing a terminal oligoguanine motif, which we refer to as mTOGs. Importantly, we show that PUS7-mediated J is critically required for mTOGs repressive functions in vivo.
Despite previous observations that TOG-containing 5 0 tRFs displace eIF4G/A from capped mRNAs and inhibit translation (Ivanov et al., 2011) , the mechanisms by which these fragments destabilize eIF4F remain to be fully delineated. In this study, we uncovered that J strongly promotes the association between mTOGs and PABPC1, which interacts with eIF4G to enhance eIF4F formation and stimulate translation (Kahvejian et al., 2005) . Thus, it is tempting to speculate that J acts as a structural ''switch'' to allow conformational changes that rewire the complex landscape of mTOG-RNA and mTOG-protein interactions important for eIF4F assembly. For example, mTOG binding may affect critical PABPC1 domains, such as the RNA-recognition motifs (RRMs) that modulate eIF4G recruitment to the cap complex (Safaee et al., 2012) . The idea that J imposes structural rearrangements to direct tRFs function is further supported by our findings that recruitment of prominent tRF-binding proteins, such as YBX1 and DHX36, is strongly inhibited by J. Interestingly, intermolecular RNA G-quadruplexes (RG4s) formation is required for YBX1 and DHX36 binding to TOG-containing tRNA halves (Lyons et al., 2017) , supporting our data that loss of J may also impact these fragments ( Figure S4F ). Our small RNA analysis indicates that PUS7 depletion perturbs different classes of tRFs, which may potentially extend the regulatory role of J to multiple tRFs in a stress or cell-type-specific manner.
There is a growing appreciation that dynamic changes in the RNA epigenetic landscape are needed to rewire the decoding of genetic information in stem cells (Roundtree et al., 2017) . Importantly, we show that PUS7 and mTOG are exquisitely regulated during stem cell fate commitment. This is consistent with a global increase in translation reported during mammalian ESC Table S5. differentiation into embryonic bodies (Ingolia et al., 2011; Sampath et al., 2008) and findings that protein synthesis differences are essential to establish and maintain cell identity and function (Buszczak et al., 2014) . Accordingly, our data illustrate that PUS7 and J directly impact the translation of genes involved in embryogenesis, mesoderm, and hematopoietic lineage specification. As such, mTOG pseudouridylation may be integral to a major RNA epigenetic program that governs protein synthesis to allow rapid cell fate specification. This supports a model whereby PUS7-mediated J functions as a molecular rheostat to control translational levels and define the boundaries between self-renewal and differentiation ( Figure 7D ). Increasing evidence suggests that this equilibrium centered on translation has a pivotal role in development and tumorigenesis (Truitt and Ruggero, 2016) . Our studies support observation in human hematological malignancies, illustrating that PUS7 and mTOGs dysfunction may perturb protein synthesis in a group of MDS patients characterized by high rates of transformation to aggressive leukemia (Dimitriou et al., 2016) . Accordingly, elevated protein synthesis impairs ESC differentiation and drives leukemia development (Di Cristofano et al., 1998; Signer et al., 2014) .
Future research will be necessary to determine whether J cooperates with other types of RNA modifications to redirect the translation machinery from and to 5 0 untranslated regions (5 0 UTRs), an emerging yet poorly understood mechanism of translational control in stem cells (Blanco et al., 2016; Fujii et al., 2017; Ingolia et al., 2011; Sendoel et al., 2017) . For example, dysregulation of m 5 C methylation of tRNA by the methyltransferase NSUN2, which inhibits 5 0 tRF accumulation, reduces global protein synthesis to impact epithelial stem cell function and cancer cells' survival (Blanco et al., 2016) . Interestingly, translation impairments in NSUN2-depleted stem cells were accompanied by remarkable differences in 5 0 UTR ribosome occupancy, which reflects pervasive translation of upstream open reading frames (uORFs) (Blanco et al., 2016; Fujii et al., 2017; Ingolia et al., 2011; Sendoel et al., 2017) . Thus, it will be important to decipher the tRFs epigenetic RNA ''code'' directing the translation machinery during development.
Our transcriptome-wide survey of the PUS7 RNA regulon reveals a striking enrichment of RNA Pol III transcripts such as Y RNAs and VT RNAs, suggesting that these RNA species may be targeted for J. For example, loss of NSUN2 and m 5 C leads to aberrant processing of Argonaute-associated small VT RNAs with microRNA-like functions that may have important roles in disease (Hussain et al., 2013 ). As such, our studies pave the way for new research opportunities aimed at dissecting the functional consequences of J in the context of VT RNAs and other PUS7 small RNA substrates. In summary, our study uncovers a J-driven RNA epigenetic program directing protein synthesis in stem cells. This reveals an additional posttranscriptional layer of regulation that may directly impact the spatiotemporal control of gene expression during development and tumorigenesis.
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact, Cristian Bellodi (cristian. bellodi@med.lu.se).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse strains NOD/SCID/g (NSG) mice were purchased from Jackson Laboratories and used for xenotransplantation studies. Mice were housed in individually ventilated cages (IVC) under controlled climate and enrichment environmental conditions (bubble material) with unlimited access to sterile food and water. Ten males and fourteen females (12-18 week-old) mice were used for xenotransplantation experiments. Littermates of the same sex were randomized to experimental groups. Experimental procedures were approved by the Lund University Ethical Committee.
Cell culture H9 human Embryonic Stem Cells (hESCs) were acquired from the WiCell Research Institute (Madison, Wisconsin, USA) with a normal 46, XX karyotype. H9 cells were cultured on feeder or feeder-free condition depending on experimental procedure. For feeders' cultures, H9 cells were grown on irradiated mouse embryonic fibroblasts (MEF), CF-1 strain (Merck Millipore, PMEF-CFL) using Knockout-DMEM (Thermo Fisher), 20% Knockout Serum (KSR, Thermo Fisher), 1% NEAA (Thermo Fisher), 1% Glutamax (Thermo Fisher), 1% Penicillin/Streptomycin (Thermo Fisher), 0.7% b-mercaptoethanol, 10 ng/mL recombinant hFGF (R&D systems). For feeders-free cultures, H9 were grown on Matrigel (VWR) coated plates and maintained in mTeSR TM 1 media (Stem Cell Technologies) following manufacturers' instructions. The quality of hESC lines was routinely assessed by alkaline phosphatase staining (Sigma) and immunofluorescence analysis of multiple pluripotent markers. HEK293T cells with hypotriploid XX karyotype, were cultured in DMEM (Thermo Fisher) supplemented with 10% fetal bovine serum (GE Healthcare) and 1% Penicillin/Streptomycin (Thermo Fisher). Generation of PUS7-KO hESCs and HEK293T cells was achieved by using CRISPR/Cas9 technology (Doudna and Charpentier, 2014) . Sequence-specific small guide RNAs targeting PUS7 exon 1 were cloned into lentiCRISPRv2 carrying spCas9 nuclease (Sanjana et al., 2014) . SpCas9 was cloned in-frame with the self-cleaving peptide P2A followed by eGFP. To obtained individual clones, GFP+ cells were sorted directly on feeders-coated 60-well Terasaki plates (Thermo Fisher) in hESC culture media supplemented with 10 mM ROCK inhibitors (BD Biosciences). Individual PUS7-KO hESC clones were screened for editing of the targeted exon, which was confirmed by Sanger sequencing and western blot analysis.
Cord blood isolation
Healthy donor cord blood was used as a source of primary hematopoietic stem and progenitor (CD34+) cells. Use of human umbilical cord blood for research was certified by the Ethical Committee at Lund University Hospital (ULUND), approval 2010/696. Human cord blood-derived CD34+ hematopoietic stem and progenitor cells were cultured in StemSpam TM SFEM media (Stem Cell Technologies) supplemented with 100 ng/mL hSCF, hTPO and hFlt3 (Peprotech). Cord blood samples are completely anonymous and no accompanying information regarding the gender is available.
Patient samples
All patients and healthy donors were enrolled at Karolinska University Hospital in Stockholm, Sweden. Patients were classified according to WHO 2008 Classification and risk-classified according to the IPSS and IPSS-R Prognostic Scoring System. Based on cytogenetic analysis and clinical information, four À7 MDS patients, two males (68 and 72 year-old, respectively) and two females (76 and 85 year-old, respectively), were selected for our studies (see also Table S5 ). No association analysis based on patient gender identity was performed as the sample size was too small. The study of patients and healthy donors derived bone marrow (BM) samples is approved by the Swedish Ethical Committee for Clinical Research.
METHOD DETAILS Apoptosis Analysis
Single cell suspensions in binding buffer containing 10 mM HEPES, 140 mM NaCl, and 2.5 mM CaCl 2 pH 7.4 were stained with Annexin V (Thermo Fisher) and propidium iodide (Sigma). Data was collected using a BD LSR Fortessa flow cytometer to measure Annexin V and propidium iodide levels. At least 20,000 events were recorded for each replicate and analyzed using FlowJo software.
Cell Cycle Analysis
Single cell suspensions were prepared and fixed/permeabilized with 70% ice-cold ethanol (Thermo Fisher). Cells were treated with 100 mg/mL RNaseA (Sigma) and stained with 10 mg/mL propidium iodide (Sigma). Data was collected using a BD LSR Fortessa flow cytometer. At least 20,000 events were analyzed using FlowJo software.
Alkaline Phosphatase staining Alkaline phosphatase staining was performed using Alkaline Phosphatase Blue Membrane Substrate Solution (Sigma). Briefly, cells were fixed in 4% paraformaldehyde (Sigma) for 1 min at room temperature and washed in water for 1 min. Staining was performed as recommended in the manufacturers' instructions for 15 min using equal amount of Alkaline Phosphatase Blue Membrane Substrate solutions. Finally, cells were washed in water for 2 min and pictures were acquired using an inverted light microscope (Nikon Eclipse 2000).
Western blotting
Cells were washed with ice-cold PBS and lysed in ice-cold RIPA lysis buffer (150 mM NaCl, 1% NP-40, 0.5% sodium-deoxycholate, 0.1% sodium dodecyl sulfate, 10 mM TrisHCl pH 8) supplemented with phosphatase and protease inhibitor cocktails (Sigma). Lysates were cleared by centrifugation at 15,000 rpm for 15 min at 4 C, supernatants were removed and assayed for protein concentration using the Quick Start Bradford Protein Assay Kit (Bio-Rad). Equal amounts of proteins (at least 20 mg) were subjected to SDS-PAGE and transferred to PVDF membranes (Bio-Rad). The following antibodies were used: mouse b-Actin (Sigma), mouse PUS7 (Sigma), rabbit PUS7 (Abcam), rabbit PUS1 (Abcam), rabbit PUS4 (Abcam), rabbit DKC1 (Abgent), mouse FLAG (Sigma), mouse Puromycin (Merck Millipore), rabbit eIF4A (CST), rabbit eIF4G (CST), rabbit eIF4E (CST), rabbit 4EBP1 (CST), rabbit PABPC1 (CST), rabbit DHX36 (ThermoFisher), rabbit YBX-1 (Abcam), mouse RPL10A (Santa Cruz), rabbit RPL30 (Abcam), rabbit NANOS1 (Abcam), rabbit METRN (Abcam), mouse DKK1 (Abcam), mouse DLL1 (Abcam), mouse DGCR6 (Abcam).
Global measurements of protein synthesis
Cells were washed twice in PBS and starved for 40 min in DMEM methionine and cysteine free media, 10% FBS dialyzed, 1% Penicillin/Streptomycin. Subsequently, cells were treated for 1 hr with 30 mCi/mL protein labeling mix (EasyTag Protein Labeling Mix, Perkin Elmer). Finally, cell pellets were washed twice in PBS and harvested for protein analysis by western blotting. For all analyses, cell lysates were prepared using standard procedures and equal amounts of total protein were separated on a 10% SDS polyacrylamide gel and transferred to PVDF membranes. Membranes were exposed at À80 C to autoradiography film (GE Healthcare) for 12-48 hr.
35
S methionine/cysteine incorporation was quantified using ImageJ software to analyze signal intensity and normalized to b-actin levels. All media and supplements were purchased from Thermo Fisher if not otherwise stated.
Measurement of protein synthesis by Puromycin incorporation
Cells were incubated for 30 min in complete culture media supplemented with 1 mM puromycin. After treatment, cells were washed twice in PBS, harvested and cell lysates were prepared following standard procedures. Equal amount of total protein were loaded on a 10% SDS polyacrylamide gel and transferred to a PVDF membrane (Bio-Rad). Puromycin incorporation was measured using antipuromycin antibody (Merk Millipore) and signal intensity was quantified using ImageJ software and normalized to b-actin levels.
Measurement of protein synthesis by OP-puro incorporation OP-puro (O-propargyl-puromycin) incorporation was used to assess protein synthesis rates in primary hematopoietic stem and progenitor cells (CD34+) as previously described (Signer et al., 2014) . CD34+ cells infected with shCTR or shPUS7 lentiviruses were cultured in media containing 20 mM OP-puro (Medchem Source) for 30 min at 37 C. Cells were fixed in 4% PFA (Sigma) for 15 min and permeabilized in 0.5% Triton X-100 (Sigma) for 20 min. The alkyne-azide reaction was performed using 5 mM Click-iT Plus Alexa Fluor 555 Picolyl Azide Toolkit (Thermo Fisher) for 30 min at room temperature. Samples were washed and cells were subjected to flow cytometric analysis using LSR Fortessa flow cytometer. Mean fluorescence intensity (MFI) for OP-puro was assessed in GFP + cell populations.
Luciferase assay H9 hESCs were transfected in 6-well plates with pRF-CrPV IGR IRES (Jack et al., 2011) construct using Lipofectamine 3000 (Invitrogen) according to the manufacturer instructions. Cells were collected 24 hr post-transfection and assayed using Dual luciferase kit (Promega). Cap and IRES activity were expressed as normalized values of Fluc and Rluc activities to the levels of the dicistronic mRNA measured by RT-qPCR with Fluc primers. Specifically, cells were divided equally for luciferase assay and quantification of total dicistronic mRNA abundance.
Cap Binding Assay
Cap binding assay was performed as described (Hsieh et al., 2010) . Briefly, hESCs were lysed in cell lysis buffer containing 10 mM Tris/HCl, 140 mM KCl, 4 mM MgCl 2 1 mM DTT, 1 mM EDTA, 1% NP-40, protease and phosphatase inhibitor cocktails (Sigma).
Lysates were incubated on ice for 30 min and spun at 12000 rpm for 30 min at 4 C. For each sample, a total of 200-300 mg protein was diluted in lysis buffer (without NP-40) to 1 mg/mL and 40 mL of pre-washed 7-methyl-GTP-Sepharose beads (Jena Bioscience) were added. Samples were incubated rotating overnight at 4 C. After incubation samples were centrifuged for 5 min at 4 C, 5000 rpm, washed twice with lysis buffer (0.5% NP-40) and twice with PBS. Finally, beads were resuspended in loading buffer, boiled at 95 C for 5 min. Supernatants were loaded on a 4%-20% gradient SDS-PAGE gel (Bio-Rad) and subjected to western blotting.
SCARLET
Scarlet was performed as previously described (Liu et al., 2013) with some modifications. At least 80 mg of total RNA were extracted using TRIzol reagent (Thermo Fisher), treated with Turbo DNase (Thermo Fisher) and the small RNA fraction (< 200 nt) enriched using RNA clean and concentrator-25 (Zymo Research). Subsequently, 5 mg of small RNA fraction was incubated with 1 mM of small RNA 5 0 -adaptor (see Table S6 ) at 70 C for 2 min and immediately transferred on ice. Samples were mixed with 12 mL of ligation mix containing T4 RNA ligase I (NEB), T4 RNA ligase buffer, 1 mM ATP, 50% PEG 8000, 2 mL Superase RNase inhibitors (Thermo Fisher) and incubated overnight at 16 C. Samples were purified and subjected to SCARLET. For each sample 15 mg of purified, adaptor-ligated, RNA were incubated with 5 pmol of hybridization oligo (Eurofins, see also Table S6 ) at 95 C for 1 min, resuspended in RNase H mix containing T4 PNK buffer (NEB), RNase H (NEB), Fast AP (Thermo Fisher) and incubated for 1 hr at 44 C. The reaction was stopped by heating the samples at 75 C for 5 min. RNA was radiolabeled with 1 mL radioactive labeling mix containing T4 PNK buffer (NEB), 2 U/mL T4 PNK (NEB), 2 mCi/mL [g-32 P]ATP) at 37 C for 1 hr and then incubated at 75 C for 5 min. Each sample was annealed with 7 pmol splint oligo and 8.5 pmol 116-mer DNA oligo (see Table S6 ) by heating at 75 C for 5 min followed by addition of 2.5 mL ligation buffer (T4 RNA ligase I buffer (NEB), 0.27 mM ATP, 57% DMSO, 5 U/ml T4 DNA ligase (NEB)) and incubated for 3.5 hr at 37
C. An equal volume of RNA urea loading buffer (Thermo Fisher) was added to the samples to terminate the ligation reaction. Samples were digested with 1 mL RNase T1/A mixture (Thermo Fisher) at 37 C for 16 hr and subsequently loaded on 10% denaturing urea-PAGE gel to isolate the ligation product, which was desalted by ethanol precipitation. Pellets were resuspended in 3 mL nuclease P1 mixture (0.33 U/mL nuclease P1 (Sigma) in 30 mM sodium acetate pH 4.8 (Thermo Fisher) and incubated at 37 C for 2 hr. Finally reactions were spotted on a TLC cellulose plastic sheet (Merck Millipore) and run for $12 hr in 100 mL running buffer (isopropanol:HCl:water, 70:15:15, v/v/v). TLC sheets were exposed at À80 C to autoradiography film (GE Healthcare) for 48-72 hr. The sequences of all SCARLET oligos are described in Table S6 .
CMCT-based RT-qPCR J quantification Quantification of J levels was performed as described (Bakin and Ofengand, 1993; Schwartz et al., 2014) with some modifications. At least 10 mg total RNA was extracted, treated with Turbo DNase (Thermo Fisher) and the small RNA fraction (< 200 nt) was isolated using RNA clean and concentrator-5 (Zymo Research). Small RNA 5 0 -adaptor (Table S6 ) was ligated to 2 mg RNA as aforementioned and CMCT treatment was performed as described (Bakin and Ofengand, 1993; Schwartz et al., 2014) . Briefly, 1 mg of small RNA fraction was precipitated in EtOH 100%, washed and resuspended in BEU buffer (50 mM Bicine, 4 mM EDTA, 7 M Urea) in the presence or absence of CMCT (Sigma). Samples were incubated 20 min at 37 C and reaction was blocked by addition of 100 mL Buffer A (100 mM EDTA, 300 mM NaOAc, pH 5.6). RNA was precipitated twice using 0.5 mL Glycoblue (Thermo Fisher), 700 mL of EtOH 100% and incubation for 30 min in dry ice. RNA was washed in EtOH 85% and resuspended in Buffer A. To hydrolize the less stable U-CMCT and G-CMCT adducts RNA pellets were resuspended in 40 mL of 50 mM Sodium Bicarbonate pH 10.4 and incubated at 37 C for 3 hr. Reactions were stopped by addition of 100 mL Buffer A. Finally, the RNA was precipitated and resuspended in 11 mL of RNase-free water. cDNA synthesis was performed using Superscript III with a mTOG sequence-specific stem loop primer as described elsewhere (Persson et al., 2009 ) with some modifications (see below mTOG quantification by RT-qPCR). For final PCR amplification, specific pairs of primers spanning the cDNA region containing the J-modified residue were used (Table S6) .
iCLIP-seq iCLIP was performed using hESCs and HEK293T cells as described (Huppertz et al., 2014) with some modifications. Two subconfluent 15 cm tissue culture plates per replicate were UV-crosslinked at 254 nm, with 200 mJ/cm 2 using UV Stratalinker 1800 (Stratagene). Cells were harvested and lysed in iCLIP lysis buffer: 50 mM Tris/HCl pH 7.4, 100 mM NaCl, 0.5% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 5 mM EDTA and protease inhibitors (Sigma). Lysates were sonicated 3 3 10 s at 20 W using a Branson sonicator. Cell extracts were treated with 5 U/mL RNase I (Thermo Fisher) and 1 U/mL TURBO DNase (Thermo Fisher) for 3 min at 37 C with shaking at 1100 rpm. Lysates were kept on ice for 5 min and centrifuged at 15000 rpm for 10 min at 4 C. Supernatants were incubated with pre-washed anti-FLAG magnetic beads (Sigma) (40 mL per replicate) for 2 hr at 4 C on rotator. Samples were washed with lysis buffer and incubated on-beads with RNase I for 5 min at 37 C with constant shaking 1100 rpm as described (Lubas et al., 2015) . Different RNase I concentrations (0, 10 and 100 U/mL) were tested to determine optimal RNA digestion (see also Figure S3C ). For iCLIP library preparation, 10 U/mL RNase I were used. Reactions were blocked adding 1 mL of high salt (HS) buffer: 50 mM Tris/HCl, 1000 mM NaCl, 0.5% Triton X-100, 0.25% sodium deoxycholate, 1 M Urea, 5 mM EDTA, 1 mM DTT). Each sample was washed twice with HS buffer at 4 C, once with PNK/Tween buffer (20 mM Tris/HCl pH 7.4, 10 mM MgCl 2 , 0.2% Tween-20) and once with wash buffer (50 mM Tris/HCl pH 7.4, 10 mM MgCl 2 ). Subsequently, samples were resuspended in 20 mL PNK dephosphorylation mix (4 mL 5X PNK buffer pH 6.5 (350 mM Tris-HCl pH 6.5, 50 mM MgCl 2 , 5 mM DTT), 0.5 mL T4 PNK (NEB), 0.5 mL SUPERase-IN RNase Inhibitor (Thermo Fisher) and incubated 15 min at 37 C. Samples were washed once with HS buffer, twice with wash buffer then resuspended in 20 mL of L3 adaptor ligation mix (2 mL 10X T4 RNA ligation mix (NEB), 1 mL T4 RNA ligase I (NEB), 0.5 mL SUPERase-IN RNase Inhibitor (Thermo Fisher), 1.5 pmol pre-adenylated L3 linker (Table S6 ), 4 mL PEG400) and incubated shaking overnight at 16 C. Next, samples were washed twice with HS buffer, wash buffer and subsequently radiolabeled in 20 mL of T4 PNK mix containing 2 mL of 10X T4 PNK Buffer (NEB), 1 mL T4 PNK (NEB), 0.5 mL fresh g-32 P-ATP (Perkin Elmer). Reactions were incubated 5 min at 37 C shaking at 1100 rpm and further washed once in HS and twice in PNK/Tween buffers. Beads were resuspended in 20 mL of 1.5 3 Nu-PAGE loading buffer (Thermo Fisher) and incubated 10 min at 70 C, 1100 rpm. Supernatant was added to 1 mL 1 M DTT and boiled 3 min at 95 C. Samples were run on a NuPAGE 4%-12% Bis-Tris gel (Thermo Fisher) and transferred to a nitrocellulose membrane 0.45 mm (GE Healthcare). The remaining iCLIP library preparation steps were performed as described (Huppertz et al., 2014) . Briefly, membranes containing protein-RNA complexes were excised and incubated in PK buffer at 37 C for 30 min with constant shaking at 1100 rpm. Reactions were terminated with an equal amount of PK buffer supplemented with 7 M urea. RNA was extracted using Phase Lock Gel Heavy tube (VWR) and ethanol-precipitated. cDNA synthesis was performed using using Superscript III (Thermo Fisher). cDNA was circularized using CircLigase II (Epicenter), annealed with 0.25 mM Cut oligo (Table S6 ) and digested with BamHI (Thermo Fisher). Digested cDNA was ethanol-precipitated and resuspended in 21 mL of water. 1 mL of cDNA was used for PCR amplification using Accuprime Supermix I with 18-21 PCR cycles. Libraries were sequenced on an Illumina MiSeq machine, with single-end for 50 cycles using MiSeq Reagent Kit v2 (50-cycles) (Illumina).
Small RNA library preparation Total RNA from WT and PUS7-KO hESCs was extracted using TRIzol reagent (ThermoFisher) and Direct-Zol RNA Miniprep (Zymo Research). 5 mg of total RNA were treated with Turbo DNase (ThermoFisher) and small RNA fraction (< 200 nt) was purified using RNA Clean & Concentrator À25 (Zymo Research). rRNAs was depleted using Ribo-Zero Gold rRNA removal kit (Illumina). RNA was purified using RNA Clean & Concentrator À5 (Zymo Research) and 50-100 ng of RNA were used for library preparation. NEXTflex Small RNA-Seq Kit v3 (Bioo Scientific) was used to generate small RNA libraries following the manufacturers' instructions. No size selection method was applied to retain all RNA species < 200 nt. Libraries were sequenced on an Illumina NextSeq 500 machine for 75 cycles, single-end, using NextSeq 500/550 High Output v2 kit (Illumina).
May-Grü nwald Giemsa staining
Cells were spun on a glass slide using a Shandon Cytospin (Thermo Scientific). Cells were fixed in Ethanol 100% and air-dried. Slides were stained 5 min in May-Grü nwald staining solution (Sigma), washed 5 min in PBS and stained for 17 min in Giemsa stain (Sigma) diluted 1:20 in deionized water. Slides were rinsed in deionized water, air-dried and images were acquired using a light microscope (Olympus BX51) with a color camera (Olympus DP73).
Transmission electron microscopy hESCs were fixed in 1.5% glutaraldehyde and 1.5% paraformaldehyde in 0.1 M Sorensen phosphate buffer with post fixation in 1% osmium tetroxide (Ted Pella, Inc.) . Samples were dehydrated in acetone series and embedded in Polybed resin (Polysciences, Inc.). Samples were sectioned using an ultramicrotome Leica EM UC7 with a 50-60 nm thickness and mounted on hexagonal copper grid (Ted Pella, Inc. Maxtaform H5). Finally, samples were stained with 4% uranyl acetate (Fluka) and 1% lead citrate (Merck Millipore) and images acquired using a FEI Tecnai Biotwin 120 kEv high-resolution microscope. mTOG quantification by RT-qPCR Quantification of mTOG was performed using sequence specific stem-loop primer for cDNA synthesis as described (Persson et al., 2009 ) with some modifications. Briefly, 200 ng of total RNA were treated with TURBO DNase (Themro Fisher), denatured at 65 C for 5 min in the presence of 50 nM sequence-specific mTOG and mir16a stem loop primers, 500 nM U6 reverse primer, 2.5 mM Oligo dT (Thermo Fisher) and 250 mM dNTPs (Thermo Fisher) final concentrations. Samples were transferred on ice for 2 min and 6.45 mL of retro transcription mix were added: 2.5 U/mL Superscript III (Thermo Fisher), 0.2 U/mL RNaseOUT (Thermo Fisher), 4 mL 5X FirstStrand buffer (Thermo Fisher), 10 mM DTT (Sigma). cDNA synthesis was performed using the following protocol: 16 C for 30 min, 60 cycles at 30 C for 30 s, 42 C for 30 s and 50 C for 1 s. Finally, cDNA was diluted 1:4 in water and 1 mL subjected to qPCR using SsoAdvanced Universal SYBR Green Supermix (BioRad). The specificity of each individual amplification was validated by gel electrophoresis and sequencing.
Transfection of synthetic oligonucleotides
Transfection of synthetic oligonucleotides in hESCs was performed using RNAiMAX reagent (ThermoFisher) according to manufacturer's instruction. Briefly, hESCs were plated as small colonies in a 6-well plate and transfected with 20 nM of scramble control, mTOG-U8 or mTOG-J8 (Dharmacon, see Table S6 ). Cells were harvested two days after transfection unless otherwise stated. For hESC-derived HSPCs, cells were transfected using RNAiMAX reagent (ThermoFisher) according to manufacturer's instruction. Briefly, cells were plated in a 12-well plate and transfected with 20 nM of mTOG-U8 or mTOG-J8 on day 0, day 4 and day 8 of hematopoietic differentiation. Transfection of primary HSPCs was performed using Lipofectamine 2000 (ThermoFisher) according to manufacturer's instruction with some modifications. mTOG-U8 or mTOG-J8 20 nM (unless otherwise stated) were incubated with 1 mL Lipofectamine 2000 for 20 min in SFEM. After incubation transfection mixture was added to 1x10
5 HSPCs in a 96-well plate.
Transfected HSPCs were subsequently analyzed for cell cycle/viability or plated for colony-forming assay in methylcellulose.
RNA pull down and Quantitative Mass Spectrometry
To identify mTOG-J8 interacting proteins, sub-confluent HEK293T (15 cm TC plate) or H9 hESC (10 cm TC plate) were transfected with 20 nM biotinylated scramble control or mTOG-J8 oligos using RNAiMAX reagent (ThermoFisher). The following day 200 cells were washed with ice-cold PBS, UV-crosslinked at 254 nm with 200 mJ/cm 2 and harvested on ice. Cell pellets were lysed in Lysis
Buffer containing 50 mM Tris/HCl pH 7.4, 100 mM NaCl, 0.5% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 5 mM EDTA, supplemented with 0.1 U/mL RNase inhibitors (ThermoFisher) and protease inhibitors (Sigma-Aldrich). Lysates were sonicated three times for 10 s at 10 W and cleared by centrifugation. Cleared extracts were incubated with pre-washed streptadivin-C1 dynabeads (ThermoFisher) for 1 hr at 4 C, rotating. After incubation beads were washed twice in Lysis buffer, twice in High-salt buffer containing 50 mM Tris/HCl, 1000 mM NaCl, 0.5% Triton X-100, 0.25% sodium deoxycholate, 1 M Urea, 5 mM EDTA, 1 mM DTT and twice in PNK/Tween buffer (50 mM Tris/HCl, 10 mM MgCl 2 , 0.2% Tween-20). For the elution, streptavidin beads were resuspended in 1.5X Laemli buffer with 100 mM DTT and incubated at 75 C for 10 min shaking at 1100 rpm. Proteins were recovered and analyzed either by western blotting or mass spectrometry (MS). For MS analysis, proteins were precipitated on ice for 1 hr in 20% trichloroacetic acid (TCA) and washed twice in 100% ice-cold acetone. Protein pellets were dissolved in 0.1% RapiGest (Waters) in 50 mM ammonium bicarbonate. Cysteine disulfide bonds were reduced with 5 mM DTT for 30 min at 56 C, alkylated with 10 mM iodoacetamide for 30 min at room temperature in the dark, and proteins were digested with sequencing grade modified trypsin (enzyme:protein ratio 1:50) at 37 C overnight. The reaction was stopped by adding trifluoroacetic acid to a final concentration of 0.5% (v/v), and RapiGest was precipitated by further incubation at 37 C for 45 min. Protein digests were dimethyl labeled on column as previously described with slight modifications (Boersema et al., 2009) . Briefly, SepPak C18 cartridges (Waters) were washed with acetonitrile and conditioned with 0.1% (v/v) formic acid. Acidified samples were loaded and washed with 0.1% formic acid. Samples were labeled by flushing the columns with labeling reagent (light, intermediate or heavy using CH 2 O (Sigma-Aldrich) + NaBH 3 CN (Sigma-Aldrich), CD 2 O (Sigma-Aldrich) + NaBH 3 CN (Sigma-Aldrich), or 13 CD 2 O (Sigma-Aldrich) + NaBD 3 CN (Sigma-Aldrich), respectively). Labeling reagents were swapped between replicates. After washing with 0.1% formic acid, labeled peptides were eluted with 80% (v/v) acetonitrile/0.1% (v/v) formic acid. Samples were dried by vacuum centrifugation and reconstituted in 4% acetonitrile/0.1% formic acid prior to MS analysis.
LC-MS/MS analysis
MS analyses were carried out on an Orbitrap Fusion Tribrid MS system (Thermo Scientific) equipped with a Proxeon Easy-nLC 1000 (Thermo Fisher). Injected peptides were trapped on an Acclaim PepMap C18 column (3 mm particle size, 75 mm inner diameter x 20 mm length, nanoViper fitting). After trapping, gradient elution of peptides was performed on an Acclaim PepMap RSLC C18 100 Å column (2 mm particle size, 75 mm inner diameter x 250 mm length, nanoViper fitting). The mobile phases for LC separation were 0.1% (v/v) formic acid in LC-MS grade water (solvent A) and 0.1% (v/v) formic acid in acetonitrile (solvent B). Peptides were first loaded with a constant flow of solvent A at 9 mL/min onto the trapping column. Subsequently, peptides were eluted via the analytical column at a constant flow of 300 nL/min. During the elution step, the percentage of solvent B increased in a linear fashion from 5% to 10% in 2 min, then increased to 25% in 50 min and finally to 60% in a further 15 min. The peptides were introduced into the mass spectrometer via a Stainless Steel Nano-bore emitter 150 mm OD x 30 mm ID; 40 mm length (Thermo Fisher Scientific) and a spray voltage of 2.0 kV was applied. The capillary temperature was set at 275 C. One full scan spectrum from m/z 375 to 1500 at resolution 60,000 FWHM was followed by MS/MS scans (resolution 15,000 FWHM) of the most intense ions (up to 10) from the full scan MS. The precursor ions were isolated with 1.6 m/z isolation width and fragmented using higher-energy collisional-induced dissociation at a normalized collision energy of 30%. The dynamic exclusion time was set to 30 s. The automatic gain control was set to 4x10 5 and 5x10 4 for MS and MS/MS, respectively, and ion accumulation times with 50 ms (MS) and 60 ms (MS/MS). The intensity threshold for precursor ion selection was 5x10 4 .
PABPC1 siRNA-mediated knockdown H9 hESCs were transfected in 6-well plates with 40 nM of siRNA PABPC1 (Dharmacon, see Key Resource Table) using RNAiMAX reagent (ThermoFisher) on the day of plating. Cells were harvested 48 hr after transfection and global protein synthesis was assessed using 35 S protein labeling mix (Perkin Elmer) as described above.
Northern blotting
Northern blot analysis was performed according to standard procedure. Briefly, 1 mg of total RNA was run on a 10% TBE-Urea gel (ThermoFisher). RNA was transferred to a Hybond-N+ membrane (GE Healthcare) and fixed by UV-crosslinking. Membrane was dried and pre-hybridized at 68 C for 20 min in PerfectHyb Plus Hybridization Buffer (Sigma). Hybridization was performed in fresh hybridization buffer containing 1x10 6 cpm/mL of 32 P-labeled LNA/DNA (Exiqon , Table S6 ) probe and 0.1 mg/mL herring sperm DNA (ThermoFisher). The membrane was hybridized at 68 C for 3 hr. Subsequently, the membrane was washed once in low stringency buffer (2X SSC, 0.1% SDS) at room temperature for 5 min and twice in high stringency buffer (0.5X SSC, 0.1% SDS) at 68 C for 20 min. Membranes were exposed at À80 C to a autoradiography film. After exposure membranes were incubated in boiling stripping buffer (0.1% SDS, 5 mM EDTA) and blot with U6 probe for loading control.
Fluidigm
Gene expression analysis in hESCs and embryonic bodies was performed using microfluidic high-throughput Fluidgm platform (BioMarkHD). Briefly, 400 ng of total RNA were retro-transcribed using the High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher). cDNA was diluted 1:5 and pre-amplified using TATAA PreAmp GrandMaster Mix (TATAA Biocenter) for 12 cycles. Pre-amplified cDNA was treated with 1.1 U/ml Exonuclease I (NEB) at 37 C for 30 min follow by incubation at 80 C for 15 min. The resulting cDNA was analyzed on a Biomark system (Fluidigm) using SsoFast EvaGreen Supermix with Low ROX (BioRad). Gene specific primers and cDNA mixes were loaded onto a 48.48 Dynamic Array IFC for gene expression (Fluidgm, BMK-M-48.48) and run for 30 cycles. Data was normalized using the geometric mean of four reference genes (GDI2, RPL7, ATP5A1, YWHAZ) using geNorm (Vandesompele et al., 2002) .
Polysome fractionation
Polysomal fractionation was performed as described (Sagliocco et al., 1996) with some modifications. Briefly, one sub-confluent 10 cm tissue culture plate of hESCs ($10x10 6 cells) was used for total and polysomal RNA isolation. Cells were washed with PBS and incubated for 10 min at 37 C in media supplemented with 10 mg/mL cycloheximide (CHX) (Sigma). Cells were immediately placed on ice, washed with ice-cold PBS with 10 mg/mL CHX and lysed in 600 mL passive lysis buffer containing 10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1.5 mM MgCl 2 , 0.25% NP-40, 0.1% Triton X-100, 320 U/mL SUPERase-In RNase Inhibitor (Thermo Fisher), 150 mg/mL CHX (Sigma), 20 mM DTT. Lysates were incubated on ice for 40 min and cleared by centrifugation at 15000 rpm for 10 min at 4 C. RNA absorbance was measured using Nanodrop UV spectrophotometer (Thermo Fisher) and normalized amounts of RNA were layered onto a linear sucrose gradient: 10%-60% sucrose (Thermo Fisher) (w/v), 25 mM Tris-HCl pH 7.4, 25 mM NaCl, 5 mM MgCl 2 , 0.1 mg/mL Heparin, 2 mM DTT in nuclease-free water and, centrifuged in a SW41Ti rotor (Beckman) for 2.5 hr at 40,000 rpm at 4 C. Fractions were collected and polysome profiles generated using a BioComp Gradient Station (BioComp). Each 650 mL fraction was immediately place on ice and 800 mL TRIzol added. RNA isolation was carried out using Direct-Zol RNA Miniprep (Zymo Research). Samples were treated with Turbo DNase (Thermo Fisher) and fractions containing polysomal RNA pooled (see also Figure S6B ). Sequencing library were generated using 1 mg of total and polysomal RNA with the TruSeq Stranded Total RNA Library Prep Kit (Illumina) according to the manufacturers' instructions. Libraries were deep sequenced on an Illumina NextSeq 500 machine with single-end 75 cycles run using NextSeq 500/550 High Output v2 kit (Illumina).
Spontaneous differentiation of hESCs hESCs were cultured on feeder cells to sub-confluence. Colonies were detached using Collagenase IV (Thermo Fisher) and washed once with embryoid body (EB) media containing KO-DMEM (Thermo Fisher), 20% KSR (Thermo Fisher), 1% NEAA (Thermo Fisher), 1% Glutamax (Thermo Fisher), 1% Penicillin/Streptomycin (Thermo Fisher), 0.7% b-mercaptoethanol. Cells were plated in ultra-low attachment 6-well plates (Thermo Fisher) in EB media, which was replaced every two days. EBs were collected for RNA analysis at differentiation day 7 and day 14. To assess differentiation, day 14 EBs were transferred on a gelatin-coated 6-well plate and culture in spontaneous differentiation media containing KO-DMEM, 10% FBS (Thermo Fisher), 1% NEAA, 1% Glutamax, 1% Pen/Strep, 0.7% b-mercaptoethanol. Media was changed every two days. Terminal differentiation toward the mesodermal lineage was assessed after additional 10 days by immunofluorescence analysis of the mesoderm marker a-SMA (Sigma).
Hematopoietic differentiation
Hematopoietic differentiation was performed using STEMdiff Hematopoietic Kit (StemCell Technologies, Inc.) following the manufacturers' instructions. Briefly, hESC were grown in mTeSR (StemCell Technologies, Inc.) and 30 small-sized colonies per condition were plated in a 12-well plate in mTeSR media. The following day (day 0 of differentiation) media was replaced with 1 mL of Medium A. Cells were cultured in differentiation media for 10 days and subsequently harvested to single cell suspensions. To determine the number of HSPCs (CD34 + /CD45 + ), cell suspensions were stained for 30 min on ice with PE a-CD45 (Biolegend) and APC a-CD34 (Biolegend) and subjected to flow cytometic analysis using LSR Fortessa flow cytometer. For CFU assay, 3 3 10 3 HSPCs were plated on a 35 mm dish (VWR) in MethoCult (StemCell Technologies, Inc.) and the number of colonies enumerated after 10 days. Cord blood-derived human CD34+ cells were infected lentiviruses expressing scramble control or PUS7-targeting shRNAs. The following day 200 cells were plated on a 35 mm dish (VWR) in MethoCult (StemCell Technologies, Inc.). Hematopoietic colonies were scored after 10 days. Flow cytometry was performed on colonies dissociated to single cell and stained with anti-human CD34-APC (BioLegend). Analysis was carried out using a LSR Fortessa flow cytometer.
Xenotransplantation studies
Human cord blood-derived CD34+ were infected with lentiviruses co-expressing the green fluorescence protein (GFP) along with scramble control or two independent PUS7-targeting shRNAs. The following day, 75x10 3 human CD34+ cells/mouse were injected into sub-lethally irradiated (250 cGy) NSG mice. A total of eight mice were transplanted for each condition. Human engraftment was assessed measuring the percentage of human CD45+/GFP+ cells in the peripheral blood (PB) of transplanted mice every two weeks over a two-months period post-transplantation. Briefly, PB was collected from the tail vein and depleted of red blood cells by incubating at 37 C for 25 min in 2% dextran solution. Residual red blood cells were lysed in ammonium-chloride. Cells were washed and stained for 30 min on ice with the following antibodies: anti-mouse CD45-AlexaFluor700 (BioLegend), anti-human CD45-APC (BioLegend), anti-human CD19-BV605 (BD Biosciences), anti-human CD15-PE (BioLegend) and anti-human CD33-PE (BD Biosciences). Next, cells were washed and resuspended in 1:100 7-AAD (BioLegend) in PBS 3% FBS and analyzed for GFP expression and surface markers on a LSR Fortessa flow cytometer. Mice were sacrificed 8-week post-transplantation and bone marrow cells were harvested and stained with the following antibodies: anti-mouse CD45-AlexaFluor700, anti-human CD45-APC. Cells were resuspended in PBS 3% FBS with 1:100 7-AAD (BioLegend) and analyzed using a LSR Fortessa flow cytometer.
Flow cytometry analysis of human CD34+ cells
Human cord blood-derived CD34+ were washed and permeabilized with 0.1% Triton X-100 in PBS for 5 min at room temperature. Cells were stained with primary antibodies for c-MYC (Abcam), HLF (Santa Cruz Biotechnology) and BMI-1 (Cell Signaling Technology) diluted 1:200 in PBS with 3% BSA for 30 minutes at room temperature. Subsequently, cells were resuspended in PBS with 3% BSA containing 1:1000 secondary antibodies conjugated with AlexaFluor594 and incubated for 30 min at room temperature. Finally, cells were analyzed using a LSR Fortessa flow cytometer.
QUANTIFICATION AND STATISTICAL ANALYSIS
In all figures, data is presented as mean, ± SD or SEM. Number of independent biological replicates used for experiments are listed in the figure legends. Statistical tests and specific p-values used are indicated in the figure legends.
Cell size measurements Quantification of cell surface and cytoplasm to nucleus ratio was carried out using a transmission electron microscope (TEM) and images were scored blindly. For each experiment more than 80 cells were measured.
Gene ontology
Gene Ontology (GO) categories represent GOTERM_BP_FAT in DAVID (https://david.ncifcrf.gov). GO terms were filtered for groups containing R 4 genes.
iCLIP-seq data analysis For hESCs 9 3 10 6 raw reads per biological replicate were obtained (see Table S1 for reads processing). Reads were sorted according to sample-specific barcodes as described (Huppertz et al., 2014) . PCR duplicates were removed based on the presence of 5 nucleotides unique sequence identifiers introduced during RT step. After trimming adaptor and barcode regions, reads were mapped to human genome hg38 using HISAT 2 using default parameters (Kim et al., 2015) . Multimappers reads were removed from subsequent analysis. Peak identification was performed using Piranha (Uren et al., 2012) with the following parameters: -p 0.05 -b 200 -d ZeroTruncatedNegativeBinomialRegression -i 200. Aligned reads from PUS7-KO sample were used to determine the noise signal. Peaks were annotated using Genecode v24 and quantified using the R package Rsubread. Peaks resulting from intergenic regions were dropped. Motif analysis was performed using the Zagros software as described (Bahrami-Samani et al., 2015) . For tRNA analysis, a tRNA fasta file was downloaded from GtRNAdb2 (http://gtrnadb.ucsc.edu/GtRNAdb2/genomes/eukaryota/Hsapi38/ hg38-tRNAs.fa) and converted into bowtie indices as described (Chan and Lowe, 2016). Bowtie version 1.1.2 was used to map tRNAs with the following parameters: -m 500 -v 2-best -strata. Data were quantified using samtools idxstats (Li et al., 2009 ) and tRNA isoacceptor cumulative reads were combined. tRNA isoacceptors with a normalized count lower than 50 were excluded from the analysis. To determine enrichment of PUS7-bound tRNAs, the number of reads from each tRNA isoacceptor was normalized over tRNA abundance determined by smRNA-seq.
Analysis of small RNA-seq data For small RNA-seq experiment aprroximately 60x10 6 raw reads were obtained per biological replicate. Reads were processed as follow: adaptor sequence (TGGAATTCTCGGGTGCCAAGG) was trimmed and additional four nucleotides at the 5 0 end and at the 3 0 end were removed following recommendations included in the NEXTflex Small RNA-Seq Kit v3 protocol (Bioo Scientific). For tRNA analysis, a tRNA fasta file was downloaded from GtRNAdb2 (http://gtrnadb.ucsc.edu/GtRNAdb2/genomes/eukaryota/ Hsapi38/hg38-tRNAs.fa) (Chan and Lowe, 2016) and converted into bowtie indices. Bowtie version 1.1.2 was used to map the sample specific fastq files to the tRNA sequences using the options '-m 500 -v2-best -strata'. The data was quantified using samtools idxstats and read counts generated for each tRNA isoacceptor were combined. For tRNA fragments (tRFs) analysis reads were annotated using MINTmap software (Loher et al., 2017) on GitHub https://github. com/stela2502/MINTmap) and further processed using the BioData R package (https://github.com/stela2502/BioData). To determine differentially expressed tRFs in WT and PUS7-KO cells, each fragment sequence was grouped according to tRNA isoacceptor, origin (5 0 , 3 0 or internal) and length (fragment or half) according to MINTmap annotation. tRNA fragment statistics were implemented in the function BioData::tRNA_stats to compare the per fragment expression of a class of tRNAs between two distinct experimental conditions. Specifically, this function collapses multiple replicates for each condition based on the tRF mean expression. To identify differentially expressed tRF groups between WT and PUS7-KO cells, tRF means were compared using a paired Student's t test. False discovery rate (FDR) was determined by generating a Benjamini and Hochberg (BH) adjusted P value.
Protein identification and quantification MS raw data files were processed with MaxQuant (version 1.6.0.16) (Cox and Mann, 2008) . Enzyme specificity was set to trypsin/P and a maximum of two missed cleavages were allowed. Cysteine carbamidomethylation was selected as fixed modification; methionine oxidation and acetylation of protein amino-terminus were selected as variable modifications. The derived peak list was searched using the in-built Andromeda search engine in MaxQuant against the Uniprot human database together with 265 frequently observed contaminants (Andromeda configured database) and reversed sequences of all entries. Initial maximal allowed mass tolerance was set to 20 ppm for peptide masses, followed by 4.5 ppm in the main search, and 20 ppm for fragment ion masses. The minimum peptide length was set to seven amino acid residues. A 1% false discovery rate (FDR) was required at both the protein level and the peptide level. In addition to the FDR threshold, proteins were considered identified if they had at least one unique peptide. The protein identification was reported as an indistinguishable ''protein group'' if no unique peptide sequence to a single database entry was identified. The 'match between runs' was enabled for consecutive peptide fractions with a 1.5 minutes time window. Ratio count 1 was used. Contaminants, reverse hits and ''hits-only-identified-by-site'' were excluded. The iBAQ algorithm was used for estimation of the abundance of different proteins within a single sample (proteome).
Polysome analysis Approximately 50x10
6 reads were sequenced per biological replicate. Reads were aligned to rRNA reference using Bowtie (Langmead et al., 2009 ). The unaligned reads were collected while the rRNA alignments were discarded to reduce rRNA contamination. TopHat (Kim et al., 2013) was used to align the non-rRNA sequencing reads to hg19 and counted for gene associations against the UCSC genes database with HTSeq (Anders et al., 2015) . R/Bioconductor package edgeR (Robinson et al., 2010) (R Development Core Team, 2017) was used to find differentially expressed genes. Only genes with raw counts > 1 in all replicates were considered for further analysis. A log 2 ratio KO to WT > or < ± 1.5 cutoff was applied for total RNA samples to remove genes transcriptionally regulated. To identify differences in the polysome dataset a log 2 ratio KO to WT > or < ± 0.7 cutoff was applied and statistically significant genes P value < 0.05 were selected.
DATA AND SOFTWARE AVAILABILITY
Raw and analyzed data for all sequencing experiment have been deposited at the GEO (https://www.ncbi.nlm.nih.gov/geo/) under the following accession numbers: GEO: GSE101004, Small RNA sequencing; GSE101005, iCLIP-seq; GSE101485, Polysome-seq. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium with the dataset identifier PXD008676. BioDAta R package used in this paper can be found at https://github.com/stela2502/BioData. Figure S1 . Characterization of PUS7-KO hESCs, Related to Figure 1 PUS7 loss does not affect viability and proliferation. (A) PUS7 is highly expressed in human embryonic stem cells (hESCs) compared to differentiated fibroblasts (HF). Graph shows mean PUS7 mRNA levels ± SD in three independent experiments. **p < 0.01 (t test). (B) Graph shows the percentage of cycling WT and PUS7-KO cells ± SD in three independent experiments. NS, no statistical significance (t test). (C) Graph shows mean cell viability ± SD in four independent experiments. NS, no statistical significance (t test). (D) PUS7 depletion impacts cap-dependent translation. Schematic depicts the dicistronic translational reporter employed to measure cap-dependent and IRESmediated translation in WT and PUS7-KO hESCs (Jack et al., 2011) . Graphs show mean RLuc or FLuc relative luciferase units (RLU) normalized to the dicistronic RNA expression ± SD in three independent experiments. *p < 0.05; NS no statistical significance (t test). (C) Heatmap shows no differences in the expression levels (log2 space normalized counts) in all tRNA-Tyr (GTA) genes between WT and PUS7-KO hESCs. Rows show individual tRNA-Tyr genes in four independent experiments (columns) performed using small RNA fractions isolated from WT and PUS7-KO hESCs. (D) Northern blot analysis shows no differences in the levels of tRNA-Tyr (GUA) or its derived internal fragments (int-tRF) between WT and PUS7-KO hESCs. 
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